Run-Rate EBITDA in M&A: How Buyers Estimate Forward Earnings

Run-rate EBITDA is a valuation argument, not just an accounting calculation

Historical earnings remain the starting point in most middle-market acquisitions, but they do not always show what the company is earning at the moment a transaction is being negotiated. A business may have implemented pricing, won contracts, eliminated costs, closed an underperforming location, improved utilization, or shifted its customer mix late in the trailing period. Those changes can make the last twelve months less representative of current operating performance. Run-rate EBITDA is the framework buyers use to decide whether the current earnings profile deserves more or less weight than the trailing record.

The concept is important because a small change in the accepted earnings base can have a large effect on enterprise value. If the buyer applies an 8.0x multiple, every $500,000 of accepted run-rate EBITDA changes indicated enterprise value by $4.0 million before debt, working capital, fees, taxes, escrow, rollover equity, or contingent consideration. The disagreement is therefore rarely about terminology alone. It is often a direct negotiation over value.

A seller pursuing a transaction should treat run-rate EBITDA as an evidence-based bridge between historical results and the earnings a buyer can reasonably expect after closing. The bridge must reconcile to the books, distinguish current performance from future initiatives, reflect all costs required to support the revenue, and survive financial diligence. That discipline is central to credible sell-side M&A advisory services because an aggressive number that does not withstand diligence can weaken the entire process.

Executive summary

Run-rate EBITDA estimates the earnings a company would generate if its current operating conditions continued for a full period. It is usually derived from recent actual results and documented operating changes rather than from a broad management forecast. Buyers compare that figure with reported EBITDA, normalized EBITDA, trailing twelve-month EBITDA, last-quarter annualized results, next-twelve-month forecasts, and pro forma EBITDA before deciding what earnings base they will use for valuation.

A credible run-rate case is supported by evidence already visible in the business. Examples include pricing that has been implemented and invoiced, signed contracts that have begun producing revenue, payroll or facility savings already realized, a discontinued loss-making activity, or a recurring margin improvement reflected in recent monthly results. A weak case relies on unsigned pipeline, unimplemented savings, temporary volume spikes, incomplete cost recognition, or annualization of a seasonally strong month.

The buyer’s accepted number is often lower than the seller’s presentation because buyers adjust for execution risk, seasonality, customer concentration, working-capital needs, incremental support costs, and the possibility that recent improvement will not persist. Quality of earnings work tests the monthly bridge, revenue recognition, gross-margin behavior, cost completeness, and cash conversion. The resulting buyer-underwritten EBITDA—not the label placed on the seller’s schedule—is what typically drives price.

The practical objective is not to maximize the displayed run-rate number. It is to present the strongest number that can be defended consistently through management meetings, financial diligence, lender review, and purchase-agreement negotiations. That is also why founders should connect the earnings case to a disciplined M&A advisory process rather than treating it as a standalone spreadsheet exercise.

Key takeaways

• Run-rate EBITDA annualizes current operating conditions; it is not automatically the same as TTM, LQA, forward, forecast, or pro forma EBITDA.
• A credible calculation starts with reconciled historical results and separates normalization add-backs from current-state run-rate adjustments.
• Implemented pricing, active signed contracts, realized savings, and durable mix changes receive more weight than unsigned pipeline, planned synergies, or future initiatives.
• Seasonality, customer concentration, support costs, working capital, capital expenditure, and cash conversion can reduce the buyer’s accepted run-rate case.
• Buyer-underwritten EBITDA—not the seller’s label—typically determines the valuation, financing capacity, and structure used in a transaction.
• Competition among buyers can reveal whether the market will capitalize the run-rate case or rely on a more conservative historical earnings base.

How buyers move from historical EBITDA to a run-rate earnings case

Buyers rarely move directly from reported financial statements to a run-rate valuation. They first reconcile the historical earnings base, separate legitimate normalization adjustments, review the latest monthly and trailing performance, identify current changes not fully reflected in the trailing period, and then test those changes through financial and commercial diligence. The sequence matters because each step has a different evidentiary standard.

A disciplined bridge keeps historical adjustments separate from forward assumptions. It also shows the buyer where the earnings case changes if one assumption is rejected. That transparency is more persuasive than presenting a single adjusted EBITDA number without a clear path back to the books.

Once the parties agree on the earnings base, the analysis continues through the valuation multiple and the broader transaction mechanics. Enterprise value must still be translated into equity proceeds after debt, cash, working capital, fees, taxes, escrow, and structure. Run-rate EBITDA is therefore one important input—not the entire valuation answer.

What does run-rate EBITDA mean?

Run-rate EBITDA means the annualized earnings implied by the company’s current operating profile. The calculation asks what EBITDA would look like over a full year if the conditions visible today continued at a reasonable, sustainable level. It is forward-looking, but it is not supposed to be a speculative forecast. The strongest run-rate calculations are anchored in actual monthly performance and changes that have already occurred.

The phrase is sometimes written as run rate EBITDA, run-rate adjusted EBITDA, EBITDA run rate, annualized run-rate EBITDA, or simply RR EBITDA. In transaction materials, those labels can describe slightly different calculations unless the schedule defines the starting period, adjustments, and annualization method. A buyer will therefore focus less on the label and more on the bridge from reported results to the proposed earnings figure.

Run-rate EBITDA should also be distinguished from the broader idea of a business run rate. Revenue, bookings, gross profit, recurring revenue, headcount expense, and working capital can each be expressed on a run-rate basis. The M&A question is whether the selected measure reflects a durable operating level and whether the assumptions are internally consistent. A revenue run rate that ignores the labor, delivery, commissions, inventory, or support costs required to produce that revenue does not establish a credible EBITDA run rate.

The distinction matters whenever a buyer moves from an initial valuation range to a formal offer. Auxo’s guide to business valuation methods explains how the earnings base interacts with multiples, discounted cash flow, and precedent transactions.

Reported, normalized, trailing, run-rate, forward, and pro forma EBITDA

M&A materials often contain several EBITDA figures because each answers a different question. Reported EBITDA shows what the accounting records produced before transaction-specific adjustments. Normalized or adjusted EBITDA removes items that are unusual, non-recurring, owner-specific, or not expected to continue. Trailing twelve-month EBITDA measures the latest twelve months. Run-rate EBITDA annualizes current operating conditions. Forward or next-twelve-month EBITDA incorporates a forecast period. Pro forma EBITDA may also reflect acquisitions, divestitures, synergies, or other changes as though they had occurred earlier.

The distinctions matter because the same company can present materially different values under each measure. TTM EBITDA in M&A provides the historical baseline, while normalized EBITDA versus adjusted EBITDA addresses the treatment of add-backs. Run-rate analysis then asks whether current operating conditions are sufficiently realized, measurable, and durable to support an annualized earnings view.

Run-rate EBITDA formula and calculation methods

There is no single formula that applies to every company because the right method depends on the business model, seasonality, available monthly data, and nature of the recent operating change. The most common calculation starts with a representative recent period, annualizes it, and then adds or subtracts only those current-state adjustments that are not already reflected in that period.

For a stable subscription or recurring-service business, a recent month may be informative if customer additions, churn, and support costs are predictable. For a project business, distributor, seasonal consumer company, or company with irregular contract timing, a single month can be misleading. In those cases, the buyer may use a weighted recent period, compare year-over-year months, or build a contract-by-contract bridge rather than multiply one month by twelve.

The selected measurement point also matters. A seller may calculate the run rate from the end of the most recent month because that is when a price increase became fully effective. A buyer may use an average of the last three or six months to reduce volatility. The difference between those approaches should be explicit. A credible schedule identifies the source period, explains why it is representative, shows every adjustment, and reconciles back to historical financial statements.

The formula should also reconcile to the model used for acquisition financing. A buyer may present one earnings case in the valuation discussion and a more conservative case in its sources-and-uses analysis if lenders do not accept every adjustment.

Seasonality, measurement periods, and when annualization fails

The choice of measurement period is often the most important judgment in the calculation. A January result may not represent a seasonal consumer business, a summer month may overstate construction activity, and a quarter-end shipment pattern may distort a manufacturer’s margin. Buyers compare the proposed period with prior years, budget, backlog, customer ordering patterns, and the timing of variable expenses before deciding whether annualization is appropriate.

When performance changes during a month or quarter, the start, middle, or end point can produce different results. A price increase effective halfway through a quarter may justify a contract-level bridge rather than multiplying the full quarter. A new location that is still ramping may require a monthly cohort model. A cost reduction completed at quarter-end may have little historical evidence even though the new expense level is known.

A representative run-rate method should reflect the company’s economics rather than force every business into a twelve-times-monthly formula. Buyers may use a rolling three-month average, a seasonally adjusted last quarter, the latest twelve months with current-state overlays, or a customer-level model. The method is more credible when management explains why it fits the business and shows how alternative periods affect the result.

In-year EBITDA versus full-year run-rate EBITDA

An in-year impact measures the amount of an operating change recognized during the current fiscal or trailing period. A run-rate impact measures the full annual effect if that change had been in place for the entire year. The distinction is especially important when pricing, hiring, cost savings, a new location, or a customer contract begins partway through the period.

Assume a company implements a price increase on October 1 that adds $100,000 of monthly EBITDA. The current calendar year may include only three months, or $300,000, of benefit. The annualized run-rate impact is $1.2 million. A seller may add the remaining $900,000 to normalized TTM EBITDA to show the full current-state economics. A buyer will then test whether the increase has been accepted by customers, whether volume or churn changed, and whether any offsetting sales commissions, service costs, or concessions must be included.

This current-year-to-next-year bridge is useful only when the change is already operating. A planned January price increase, an unsigned contract, or a cost initiative that has not been executed belongs in a forecast rather than a current run-rate calculation. Mixing those categories can make an otherwise valid earnings presentation appear promotional.

If the parties use a fixed purchase price, the run-rate bridge may influence negotiation without becoming a mechanical closing adjustment. Separate purchase price adjustments typically address debt, cash, working capital, and specified balance-sheet items.

Run-rate EBITDA versus LQA EBITDA

Last-quarter annualized EBITDA, often called LQA EBITDA, multiplies the most recent quarter by four. It is a convenient form of run-rate analysis, particularly in private equity models, because it captures the latest operating level without relying on a single month. It can also provide a quick comparison with trailing twelve-month results when the business is growing or margins are changing rapidly.

LQA is not automatically more accurate than TTM EBITDA. A quarter may contain seasonal demand, a temporary backlog release, a favorable product mix, unusually low hiring, delayed expenses, or a customer timing benefit. A disciplined buyer compares the quarter with prior-year quarters, monthly trends within the quarter, backlog and bookings, staffing levels, and the working capital required to support the activity.

Private equity buyers may show both LQA and a more conservative run-rate case. The LQA case describes what the recent quarter would produce if repeated. The run-rate case may then adjust that annualization for known churn, cost normalization, seasonality, or current-state changes. The distinction helps the investment committee understand how much of the earnings bridge comes from actual recent performance and how much comes from additional judgment.

The buyer may also compare the LQA case with the company’s free-cash-flow profile. High annualized EBITDA that requires unusual capital spending or working capital may not support the same valuation as a lower but more cash-generative case, a distinction explored in the EBITDA-to-free-cash-flow bridge.

Run-rate adjustments versus EBITDA add-backs

A normalization add-back changes the historical earnings base because an expense or income item in the reported period is not expected to recur under normal ownership. A run-rate adjustment changes the annualized effect of an ongoing operating condition because the trailing period contains only part of that condition. The two concepts can overlap, but they should not be collapsed into one undifferentiated adjustment schedule.

For example, a one-time litigation expense may be a normalization adjustment. A facility closure completed six months ago may create both a historical normalization question and a run-rate question: the company may add back non-recurring closure costs and separately annualize the ongoing rent and payroll savings not fully reflected in TTM EBITDA. Each component needs different evidence and must be checked for double counting.

Buyers often challenge schedules that label every favorable difference as “adjusted EBITDA.” Separating reported EBITDA, historical normalization adjustments, TTM EBITDA, current-state run-rate adjustments, and future forecast initiatives makes the logic easier to test. That separation also aligns the analysis with quality of earnings versus normalized EBITDA, which explains why an adjustment presentation and a diligence conclusion are not the same thing.

The same discipline applies to owner compensation, one-time professional fees, litigation, transaction expenses, and restructuring costs. The article on normalized EBITDA and QoE in middle-market valuation provides a broader framework for evaluating those historical items.

Run-rate adjustments buyers are more likely to support

Implemented pricing can support a run-rate adjustment when invoices demonstrate the new price, customer retention remains acceptable, and the resulting margin is visible. The buyer will often compare realized price with contractual price, test whether volume fell, and determine whether commissions, rebates, freight, service requirements, or other variable costs changed. The adjustment should reflect the net EBITDA effect rather than the gross revenue increase.

Signed customer contracts can also support a run-rate case when service has begun, the revenue start date is clear, delivery capacity exists, and the associated labor and operating costs are included. A contract that has been signed but has not started may receive partial or no credit depending on cancellation rights, implementation risk, customer dependencies, and the time required to reach steady-state margins.

Realized cost savings are often supportable when payroll records, lease terminations, vendor agreements, or closed-facility expenses show that the cost has actually left the business. Buyers will distinguish permanent savings from deferred spending. A vacant position that must be refilled, temporarily reduced marketing, delayed maintenance, or below-market owner compensation may not represent sustainable savings.

A favorable mix shift may support run-rate EBITDA when the recent sales mix is established, customer demand is durable, and the gross-margin improvement reconciles to transaction-level or product-level data. Buyers will be cautious when the change reflects one large order, a temporary supply constraint, a short-lived backlog release, or an unusually profitable project that cannot be repeated.

Supportable adjustments are not automatically permanent. Buyers compare the evidence with customer retention, supplier terms, labor availability, and implementation capacity. That review is part of how buyers identify hidden risk during diligence.

Adjustments buyers commonly reject or discount

Unsigned pipeline is not current run-rate EBITDA. Even when management has high confidence in a prospective customer, the revenue remains subject to conversion, timing, implementation, and margin risk. Buyers may consider the pipeline in a forecast or earnout discussion, but they generally resist capitalizing it as if it were already part of the operating base.

Unimplemented cost savings are also vulnerable. A plan to reduce headcount, consolidate facilities, renegotiate suppliers, or automate a process may be commercially sensible, but it belongs in a synergy or improvement case until the action is complete and the business can operate at the lower cost. The same principle applies to future pricing, expected procurement savings, and planned productivity gains.

Temporary peaks create another common problem. Annualizing the strongest month or quarter can overstate earnings when demand is seasonal, project timing is uneven, customer orders were pulled forward, or expenses lagged revenue. Buyers may normalize the selected period using historical seasonality or use a blended average rather than accept the highest available snapshot.

Finally, buyers reject calculations that annualize revenue without the full cost base. New customer revenue may require account management, implementation staff, commissions, working capital, inventory, warranty exposure, or capital expenditure. Run-rate EBITDA should include the costs required to sustain the run-rate revenue, not only the contribution visible before the operating model catches up.

An aggressive adjustment schedule can create broader credibility problems and contribute to the late-stage value erosion described in why deals lose value during due diligence.

When run-rate EBITDA is lower than TTM EBITDA

Run-rate analysis is not always favorable to the seller. A major customer loss, margin compression, wage inflation, pricing pressure, expiring contract, facility issue, or reduced backlog may make current earnings weaker than the trailing record. In that situation, a buyer may argue that TTM EBITDA overstates the company’s present earnings power.

A reduced run-rate EBITDA reflects the annualized effect of deterioration already visible in the business. If a customer representing $500,000 of annual EBITDA leaves near the end of the trailing period, TTM results may contain most of that contribution even though it will not continue. The buyer will subtract the full run-off effect when underwriting the post-close business.

Sellers should address negative run-rate developments directly. Attempting to anchor valuation solely to historical EBITDA when the operating profile has changed can damage credibility. The appropriate response may involve showing replacement revenue, cost actions, retention evidence, or a structured payment tied to recovery. Run-rate analysis should be symmetrical: current improvements deserve consideration only if current deterioration is also recognized.

If the deterioration is material and not disclosed early, the issue can threaten closing rather than merely reduce price. Auxo’s article on why buyers walk away late in M&A deals explains how unexpected performance changes affect confidence and execution.

How signed contracts, backlog, and bookings affect run-rate EBITDA

Signed contracts are one of the strongest potential foundations for a run-rate bridge, but contract status alone does not determine valuation credit. Buyers evaluate whether the contract is cancellable, whether minimum volumes exist, whether pricing can be changed, whether implementation milestones remain, and whether the company has the people, inventory, equipment, or licenses required to perform.

Backlog can support the bridge when it represents contracted, profitable work with a reliable conversion history. A services company may translate backlog into monthly revenue and margin based on staffing capacity. A manufacturer may analyze scheduled releases, material costs, tooling, and customer forecasts. A software or recurring-services company may focus on activation dates, churn, implementation costs, and annual recurring revenue conversion.

Bookings without executed agreements generally receive less weight. They can strengthen the broader growth narrative, but the seller should not blend them with current run-rate EBITDA unless the company’s historical conversion is exceptionally reliable and the buyer explicitly agrees with the methodology. Keeping contracted current-state earnings separate from prospective forecast earnings improves credibility.

The contract analysis should be coordinated with revenue recognition and customer concentration review. Those diligence questions often determine whether a buyer treats backlog as current earnings, forecast support, or simply a commercial opportunity.

How run-rate EBITDA differs across business models

Recurring-revenue businesses can often build a run-rate from active customers, contracted recurring revenue, churn, gross margin, and current support costs. Buyers still test cohort behavior, implementation, renewals, and customer concentration, but the contractual base can make annualization more transparent than in a project business.

Project and professional-services businesses require closer attention to backlog conversion, utilization, staffing, project margins, and the timing of completion. A strong recent quarter may reflect a backlog release rather than a repeatable operating level. Buyers often build the run rate from signed backlog, expected delivery capacity, and normalized utilization rather than annualizing revenue alone.

Manufacturers and distributors must connect the run rate to volume, price, material costs, labor, freight, inventory, rebates, and working capital. A price increase may be offset by commodities or customer concessions. A volume increase may require inventory and overtime. The earnings case should reconcile to gross margin and cash requirements.

Multi-location businesses may use mature-unit performance, same-store results, new-unit ramps, closures, and centralized overhead. Buyers distinguish earnings already produced by open locations from future earnings expected when new locations mature. The latter may support a forecast, but it is not necessarily current run-rate EBITDA.

These differences are why the same run-rate formula should not be applied mechanically across industries. The buyer’s method must reflect the operating cycle, the visibility of demand, and the costs required to deliver the annualized revenue.

Pricing, gross margin, and run-rate EBITDA margin

A run-rate EBITDA margin expresses annualized run-rate EBITDA as a percentage of annualized revenue. The ratio helps buyers test whether the forward earnings case is consistent with the company’s current margin structure. A seller may present strong revenue growth, but if the implied run-rate margin expands sharply without a clear operating explanation, the buyer will examine the assumptions closely.

Implemented pricing can increase run-rate margin when the price change reaches the customer without a corresponding rise in cost or churn. Buyers will test invoice-level realization, discounting, rebates, customer losses, and volume changes. A stated price increase of 8% does not necessarily create an 8% revenue or EBITDA improvement if contract renewals are staggered or customer behavior changes.

Margin improvement can also result from mix, utilization, procurement, or productivity. The buyer’s question is whether the driver is repeatable. A current margin supported by multiple months, stable customer behavior, and operational data is more persuasive than a single favorable period. The EBITDA-to-free-cash-flow bridge remains relevant because an improved accounting margin may still require additional working capital or capital expenditure.

Acquisitions, divestitures, and pro forma run-rate EBITDA

When a company has completed an acquisition during the trailing period, pro forma run-rate EBITDA may present the combined business as though the acquisition had been owned for the full period. The schedule should separate the acquired company’s historical earnings, purchase-accounting effects, realized integration changes, and future synergies. Buyers and lenders often apply different standards to each component.

A completed divestiture can create the opposite issue. TTM results may include revenue, costs, and overhead associated with a business that is no longer owned. The seller may remove the divested earnings and show the remaining company’s current cost structure. The buyer will then test whether stranded overhead remains and whether the company has actually resized the organization.

Run-rate synergies deserve particularly careful treatment. A strategic acquirer may identify procurement, facility, or overhead savings that are unique to its ownership. Those buyer synergies can support the acquirer’s willingness to pay, but they are not automatically part of the seller’s standalone EBITDA. Presenting buyer-specific synergies as seller run-rate EBITDA can create confusion between the value of the company and the value created by the combination.

The financing model may also cap acquisition-related or synergy add-backs even when the equity buyer recognizes them. Sellers should distinguish purchase-price value from lender covenant treatment and from the accounting presentation of the combined company.

Day-one, current, and closing EBITDA

Day-one run-rate EBITDA describes the earnings profile expected when the buyer takes ownership. Current EBITDA describes the company’s operating level at the measurement date. Closing EBITDA may be used informally to describe the latest earnings view at or near closing. These terms are not standardized, so transaction teams should define the period, assumptions, and source data rather than relying on shorthand.

The earnings view can change during a sale process because several months may pass between initial marketing, letter of intent, quality of earnings work, financing, and closing. A company that continues to grow may argue that the original valuation should be refreshed. A company that misses its plan may face a buyer request to reduce price or change structure. Monthly reporting and a transparent bridge are therefore essential throughout exclusivity.

The purchase agreement usually does not adjust price automatically for changes in EBITDA unless the parties specifically negotiate an earnout, performance condition, purchase-price mechanism, or other provision. The economic impact is more often handled through negotiation before signing or closing. Sellers should understand that a strong run-rate presentation can support value, but it does not replace careful drafting of the transaction terms.

A completion-accounts structure may update certain closing balances after completion, while a locked-box structure fixes the equity price using an earlier balance sheet subject to leakage protections. The guide to completion accounts versus locked box explains why those pricing mechanisms are separate from the run-rate EBITDA debate.

How financial due diligence and quality of earnings test run-rate EBITDA

Financial due diligence examines whether the proposed run-rate adjustment is mathematically correct, supported by source documents, reflected in recent results, and sustainable. The diligence team may rebuild monthly revenue and gross profit, trace customer contracts, inspect invoices, compare payroll periods, analyze headcount, review leases, test accruals, and reconcile the schedule to the general ledger.

The review also looks for costs that have not yet appeared. A new contract may be generating revenue before the company hires the full delivery team. A facility closure may create severance, moving, or duplicated overhead. A pricing increase may lead to churn or rebates. A recent quarter may benefit from delayed bonuses, maintenance, insurance, or professional fees. These timing effects can cause a run-rate calculation to overstate steady-state earnings.

Quality of earnings providers may present seller-adjusted EBITDA, diligence-adjusted EBITDA, and a separate run-rate or pro forma schedule. Auxo’s guide to normalized EBITDA and QoE in middle-market valuation provides additional context on how those analyses interact. The buyer then decides which elements to accept. The analysis in what buyers flag in a quality of earnings review explains why unsupported add-backs, revenue recognition, cut-off issues, customer concentration, and working-capital trends can affect the result.

A seller-side review before outreach, coordinated through a founder-focused sell-side M&A advisor, can identify these issues while management still has time to improve the documentation. That work should not be used to manufacture earnings. Its value is to reconcile the operating story to the financial record and determine which current-state improvements can be defended under buyer scrutiny.

When diligence confirms the bridge, the seller can use the findings to reinforce valuation and reduce the buyer’s ability to reopen settled points. When diligence contradicts the bridge, the seller should resolve the issue before it becomes a broader process problem.

Buyer-underwritten EBITDA is the number that drives price

Management may calculate one run-rate number, the sell-side advisor may present another range, the quality of earnings provider may identify a diligence-adjusted case, and the buyer may ultimately underwrite a more conservative figure. The accepted earnings base is the number the buyer believes it can defend to its investment committee, lenders, board, or strategic decision-makers.

Buyer-underwritten EBITDA reflects both evidence and risk. The buyer may accept the existence of a pricing increase but discount its annual impact because renewals are staggered. It may recognize a signed contract but reduce the expected margin because hiring is incomplete. It may accept a cost reduction while adding back a replacement manager or deferred maintenance expense. These are not merely accounting disputes; they are judgments about sustainable cash flow.

The seller’s objective is to narrow the gap before exclusivity. A well-prepared M&A advisor for selling a business can show buyers the monthly bridge, provide the supporting files, explain the operating context, and invite bids on a common information set. When several buyers underwrite the same evidence, the process can reveal whether the market will capitalize the run-rate case rather than leaving that question to a single acquirer.

A buyer may still apply a range rather than a single figure, especially when recent changes have limited history. That range can be reflected in price, financing, or contingent consideration, depending on how much uncertainty remains.

How run-rate EBITDA affects valuation multiples and enterprise value

Run-rate EBITDA affects valuation through the earnings base to which the multiple is applied. It can also affect the multiple itself. A company with improving, well-supported current earnings may appear more scalable and less risky, while a company relying on aggressive annualization may cause buyers to reduce both the accepted EBITDA and the selected multiple.

A forward EV/EBITDA multiple can look lower than a trailing multiple even when enterprise value is unchanged. If enterprise value is $48 million, TTM EBITDA is $5 million, and forward EBITDA is $6 million, the transaction is 9.6x TTM EBITDA but 8.0x forward EBITDA. The lower forward multiple does not mean the buyer paid less; it reflects a larger denominator. Sellers should identify which earnings period is being used whenever comparable transactions or buyer offers are discussed.

The pages on EBITDA multiples versus revenue multiples, how buyers use EBITDA multiples, and how an EBITDA multiples calculator should be interpreted provide the broader multiple context. Run-rate EBITDA does not determine the appropriate multiple by itself. Customer quality, growth durability, management depth, concentration, capital intensity, cash conversion, and buyer competition continue to influence the valuation range.

The selected earnings base should also be reconciled to enterprise value versus equity value. A stronger run-rate case may increase enterprise value, but it does not eliminate debt, debt-like items, working-capital adjustments, or other deductions from seller proceeds.

A formal valuation engagement may be appropriate when the company needs a transaction-oriented analysis that reconciles historical earnings, current performance, market multiples, and buyer-specific risk. Auxo’s valuation services page describes that broader work.

Run-rate EBITDA valuation sensitivity

Because run-rate assumptions can be judgmental, a sensitivity analysis is often more useful than presenting one number as certain. The seller can show a historical case, a documented current-state case, and a management forecast case. The buyer can then identify which assumptions it accepts and how the resulting value changes at different multiples.

The table illustrates why the parties should negotiate both the earnings base and the multiple. A buyer may appear to agree with the seller’s headline valuation while using a higher run-rate EBITDA and a lower multiple, or a lower EBITDA and a higher multiple. The economic result can be similar, but the framing matters for lender leverage, rollover equity, future performance comparisons, and any earnout tied to EBITDA.

A directional valuation tool can help an owner understand the arithmetic, but it does not resolve the underwriting judgment. The article on how buyers interpret valuation calculators explains why a calculated range must be reconciled to buyer-specific risk and evidence.

Sensitivity analysis is particularly useful before signing exclusivity because it lets the seller compare how different buyers treat the same operating evidence. A buyer that accepts more of the run-rate case may still offer weaker terms elsewhere, so the full package must be evaluated.

Worked example: seller run-rate EBITDA versus buyer-accepted EBITDA

Consider a business with $4.2 million of reported TTM EBITDA. Management identifies $600,000 of valid historical normalization adjustments, producing $4.8 million of normalized TTM EBITDA. It then presents $600,000 of current-state improvements from pricing, a signed contract, and a facility consolidation, resulting in a $5.4 million run-rate case.

The buyer does not reject the seller’s operating story. It accepts each driver but underwrites a smaller net impact. The $150,000 EBITDA difference becomes a $1.2 million enterprise-value difference at an 8.0x multiple. The seller can respond by providing stronger renewal data, customer retention evidence, staffing plans, and facility-cost support, or by using competition among buyers to test whether another acquirer will accept more of the bridge.

Even after the parties agree on enterprise value, the seller must evaluate actual proceeds. Debt, cash, debt-like items, working capital, transaction fees, escrow, rollover equity, seller notes, and earnouts can change the result. That is why owners asking how much a business is worth should distinguish the accepted run-rate earnings case from the final equity proceeds calculation.

The final proceeds bridge should separately account for net debt, debt-like items, and the agreed working-capital peg. Those items can change cash at closing even when the parties agree on run-rate EBITDA and enterprise value.

Most private-company transactions are negotiated on a cash-free, debt-free basis, which is another reason the EBITDA-derived enterprise value should not be confused with the amount ultimately paid to shareholders.

How private equity firms and lenders use run-rate EBITDA

Private equity firms use run-rate EBITDA because acquisition returns depend on the earnings available after closing, the leverage the business can support, and the exit value of the investment. Sponsors often compare TTM, LQA, current run rate, management forecast, and a downside case. The investment committee typically wants to know which portion of the earnings bridge is historical, which is realized, and which remains dependent on execution.

Lenders may apply a narrower definition. Credit agreements often specify which cost savings, synergies, acquisitions, or run-rate adjustments can be included in covenant EBITDA, sometimes with caps, time limits, and documentation requirements. A lender’s permitted EBITDA add-back does not necessarily mean an equity buyer will pay for the same amount, and a buyer’s purchase-price case does not necessarily determine covenant EBITDA.

Leverage can amplify the importance of the accepted number. If the seller presents $6 million of run-rate EBITDA but lenders underwrite $5 million, the sponsor may have less debt capacity and need more equity. That funding difference can affect price, financing certainty, and structure. The article on how private equity prices deals in practice explains why cash flow, leverage, required returns, and exit assumptions all matter alongside the headline multiple.

The sponsor’s return model may also use a different exit-year EBITDA than the entry run rate. That distinction matters because paying a lower forward multiple today does not guarantee an attractive return if the assumed growth, margin, or exit multiple is not achieved.

Acquirers building a repeatable underwriting process can use buy-side M&A advisory support to connect the run-rate case with target screening, valuation, diligence, financing, and integration planning.

Run-rate EBITDA, working capital, and cash conversion

A stronger run-rate EBITDA case does not automatically produce stronger cash flow. Revenue growth may require receivables, inventory, payroll, implementation spending, or customer acquisition costs before cash is collected. Buyers therefore compare the earnings bridge with working-capital trends and the company’s ability to convert EBITDA into free cash flow.

If the proposed run rate depends on a large new customer, the buyer may model the associated receivable days, inventory build, vendor terms, and implementation costs. If pricing improves EBITDA but customers take longer to pay, the economic benefit may be smaller than the income statement suggests. If cost reductions defer maintenance or capital spending, the buyer may adjust the free-cash-flow case even if EBITDA rises.

The working-capital peg is usually based on a normalized operating level, so a growing run-rate business may require a higher target at closing. The distinction between a revenue peg and working-capital peg is important because revenue growth alone does not determine the amount of operating liquidity the buyer expects. Sellers should model both the earnings benefit and the balance-sheet requirement.

Unexpected working-capital requirements can become a closing price chip even when the earnings case is accepted. The guide to avoiding working-capital price chips explains how historical seasonality and growth should be addressed before the target is negotiated.

How valuation gaps over run-rate EBITDA affect deal structure

When the seller and buyer cannot agree on how much run-rate EBITDA deserves immediate purchase-price credit, they may use structure to allocate the risk. An earnout can pay additional consideration if the disputed earnings materialize after closing. Rollover equity can allow the seller to participate in future value. A seller note can bridge financing or valuation, although it exposes the seller to repayment risk.

Structure should not be treated as economically equivalent to cash at closing. An earnout depends on definitions, control, measurement periods, accounting policies, and post-close conduct. Rollover equity depends on leverage, governance, dilution, future acquisitions, and exit timing. A seller note depends on subordination, security, interest, maturity, and the buyer’s ability to pay.

A well-run sell-side transaction process compares offers on a risk-adjusted basis rather than simply accepting the buyer that cites the highest run-rate number. The same enterprise value can produce different seller outcomes depending on how much is paid at closing, how the working-capital target is set, and how contingent consideration is drafted.

Owners should evaluate the bridge from headline value to actual proceeds, not merely the stated multiple. Enterprise value to seller proceeds provides the broader framework for that comparison.

How run-rate EBITDA appears in marketing materials, LOIs, and purchase agreements

A confidential information memorandum may show reported, normalized, TTM, and run-rate EBITDA to explain the company’s current trajectory. The presentation should define each measure and reconcile the bridge. Buyers may reference one of those figures in an indication of interest or letter of intent, but the document should make clear whether the stated multiple is applied to a fixed amount, a diligence-confirmed amount, or a forecast measurement.

Ambiguity at the LOI stage can become a retrade later. A buyer may write “8.0x EBITDA” while assuming its own quality of earnings adjustments and run-rate methodology. The seller may interpret the same phrase as 8.0x the management case. The parties should identify the relevant period, treatment of adjustments, and the process for resolving differences before exclusivity.

Definitive purchase agreements more commonly state a fixed purchase price and closing adjustments rather than a multiple. The multiple remains part of the commercial history but is not always the operative legal formula. When contingent consideration is tied to EBITDA, the agreement must define accounting principles, permitted expenses, allocations, management charges, acquisitions, and other post-close decisions that could change the result.

If the parties cannot agree on the earnings base, they should not assume the disagreement will disappear in confirmatory diligence. The LOI should preserve enough flexibility to compare structure, diligence conditions, and closing certainty before the seller gives up market leverage.

Why buyer competition matters when run-rate EBITDA is disputed

One buyer may accept the seller’s run-rate case because the company fills a strategic gap, while another may rely primarily on TTM EBITDA. A sponsor with an existing platform may underwrite cost savings or cross-selling differently from a standalone financial buyer. The market response is therefore more informative than a generic debate about the “correct” number.

A controlled sell-side advisory process for middle-market companies gives qualified buyers the same monthly financials, adjustment bridge, operating evidence, and management explanation. Bids can then be compared based on accepted EBITDA, multiple, structure, diligence conditions, and financing certainty. The article on why multiple buyers can increase business valuation explains how competition limits a single buyer’s ability to define the most conservative case without challenge.

An M&A auction process is not appropriate for every company, but the principle remains relevant: the seller should avoid granting exclusivity before it understands how different buyers view the earnings bridge. Once only one buyer remains, disagreements over run-rate EBITDA can become late-stage price leverage.

A broader competitive M&A process can also improve terms beyond price by giving the seller alternatives when one buyer applies a particularly conservative earnings case.

When bids differ, owners can use the framework in how founders should compare two M&A offers to evaluate accepted EBITDA, headline price, cash at closing, structure, diligence conditions, and execution risk together.

How sellers can defend run-rate EBITDA before going to market

The strongest defense begins with a monthly bridge from reported EBITDA to normalized TTM EBITDA and then to run-rate EBITDA. Every adjustment should have a source file, an effective date, a clear annualization method, and an explanation of whether the benefit is already reflected in the selected period. The schedule should identify offsetting costs and show that the same item has not been counted twice.

Pricing support should include customer notices, contracts, invoices, realization data, volume, churn, discounts, and margin effects. Contract support should include executed agreements, start dates, implementation status, revenue schedules, staffing, direct costs, and cancellation terms. Cost-savings support should include payroll, severance, lease documents, vendor agreements, facility records, and evidence that operations remain adequately resourced.

Management should also prepare a downside explanation. Buyers gain confidence when the company can identify seasonality, concentration, ramp risk, and cost requirements rather than presenting only the most favorable case. A transparent sensitivity model makes it easier to distinguish a defendable current-state case from a management forecast.

An experienced advisor for founder-led business sales should pressure-test the schedule before buyer diligence. The purpose is not to remove every judgment. It is to make the judgment traceable, internally consistent, and credible enough to remain stable when the buyer, quality of earnings provider, and lenders review it independently.

Owners that need more time to develop the support package may benefit from a sell-side readiness assessment before approaching buyers. The review can identify reporting, documentation, management, and diligence gaps that would otherwise weaken the run-rate presentation.

The evidence package should also be incorporated into the timing and sequencing described in the sell-side M&A process, so that buyers receive support before they anchor to a more conservative interpretation.

Common run-rate EBITDA mistakes that weaken valuation

The first mistake is annualizing the best month rather than a representative period. The second is adding current-state benefits to a monthly base that already includes them. The third is recognizing revenue without the full labor, implementation, commission, inventory, or support cost required to sustain it. Each error overstates the earnings bridge and can damage confidence beyond the amount of the disputed adjustment.

Another mistake is combining normalization, run-rate, forecast, and buyer synergies in one line labeled adjusted EBITDA. Buyers need to understand which items correct historical results, which annualize current conditions, and which depend on future execution. A clear hierarchy prevents management optimism from being confused with accounting normalization.

Sellers also weaken their position when they rely on headline multiples without specifying the denominator. An 8.0x TTM offer may be economically stronger than a 9.0x run-rate offer if the second buyer uses a much larger EBITDA figure or shifts consideration into an earnout. The accepted earnings base, selected multiple, and payment structure must be read together.

Finally, owners sometimes wait until buyer diligence to build the bridge. By then, the buyer controls the timetable and may frame every unsupported item as a reason to reduce price. Advisors who cannot explain the earnings case early can also undermine credibility, which is why how buyers evaluate M&A advisors matters in a live process.

The broader lesson is that valuation should be triangulated rather than reduced to one annualized number. Buyers compare current earnings with historical performance, cash flow, risk, and market evidence before deciding what they are willing to pay.

Seller takeaway

A Market Value Study can help an owner test whether likely buyers will recognize the proposed current-state earnings case before launching a full process.

Frequently asked questions

Related Auxo resources

Run-rate EBITDA is most useful when owners connect the earnings bridge with valuation, buyer process, readiness, and the final proceeds calculation. The resources below provide that broader transaction context.

Advisory and valuation planning

• Mergers & Acquisitions Advisory Services — Auxo’s broader advisory hub for business sales, acquisitions, recapitalizations, valuation, and transaction execution.
• Sell-Side M&A Advisory Services — Senior-led preparation, buyer outreach, offer comparison, diligence, negotiation, and closing support.
• Capital Advisory Services — Guidance on debt, private capital, recapitalization, acquisition financing, and liquidity alternatives.
• Business Valuation Calculator — A preliminary tool for testing how earnings, multiples, debt, and working capital affect value.

Sale preparation and process

• Sell-Side M&A Process — How preparation, outreach, indications, diligence, negotiation, and closing are sequenced.
• Market Value Study — A structured way to test valuation and buyer demand before committing to a full sale process.
• Sell-Side Readiness Assessment — An early review of financial, operational, management, and diligence preparedness.
• Choosing the Right M&A Advisor — A framework for evaluating experience, process design, senior attention, and execution capability.

Closing economics and seller proceeds

• Enterprise Value to Seller Proceeds — How headline value changes after debt, cash, working capital, fees, taxes, and structure.
• Cash-Free, Debt-Free Transactions — Why enterprise value and equity proceeds are different in private-company M&A.
• Earnouts in Middle-Market M&A — How contingent consideration can bridge disagreements over future earnings.
• Rollover Equity in Middle-Market M&A — How retained ownership can preserve upside while changing liquidity and risk.

Together, these resources help owners move from a run-rate earnings calculation to a complete transaction assessment that accounts for buyer underwriting, financing, structure, and actual seller proceeds.

Media & press inquiries

Auxo Capital Advisors welcomes inquiries from journalists, editors, podcast producers, and event organizers covering run-rate EBITDA, forward earnings, quality of earnings, private equity underwriting, valuation multiples, and middle-market M&A.

For media requests related to this article, please email info@auxocapitaladvisors.com.

About the author

George Barsom is Founder & Managing Director of Auxo Capital Advisors. He advises founder-led and middle-market businesses on valuation, sell-side preparation, buyer outreach, transaction process management, and negotiated M&A outcomes.

His work frequently involves translating company-specific operating and strategic attributes into buyer-underwriting language that can withstand diligence and improve negotiation leverage. That perspective informs Auxo’s published guidance across Mergers & Acquisitions Advisory Services, Capital Advisory Services, and Valuation Services.

Disclosure

This article is provided for general informational purposes only and reflects common M&A, financial-diligence, EBITDA, valuation, financing, and transaction-structure concepts. It is not legal, tax, accounting, investment, lending, valuation, credit, securities, or transaction-specific advice. The treatment of reported EBITDA, normalized EBITDA, run-rate adjustments, forecasts, working capital, debt, and purchase price depends on the parties, industry, documentation, governing agreements, and company-specific facts.

Any examples, amounts, margins, multiples, formulas, adjustment bridges, valuation sensitivities, and transaction scenarios are simplified and illustrative. Actual outcomes depend on earnings quality, customer behavior, seasonality, working capital, capital expenditure, cash conversion, buyer assumptions, financing markets, diligence findings, legal and tax structure, and negotiated terms. No valuation, financing result, payment, or transaction outcome is implied or guaranteed.

Third-party references to, citations of, summaries of, or links to this article do not constitute Auxo Capital Advisors’ review, approval, endorsement, affiliation, or adoption of any third party’s statements, services, conclusions, data, financing terms, legal interpretations, or transaction guidance. Auxo Capital Advisors is not responsible for the accuracy, completeness, context, or use of this article by any third party.

This article and its original text, analysis, frameworks, tables, graphics, and organization are protected content of Auxo Capital Advisors. Limited quotation with clear and accurate attribution is permitted for legitimate commentary or reference. Reproduction, substantial paraphrasing, republication, commercial reuse, scraping, dataset creation, model training, or other artificial-intelligence training or retrieval use is prohibited without prior written permission.